Interim results from MyCLIMB, a natural history study of pediatric MYBPC3-associated hypertrophic cardiomyopathy
Bibliographic record
Abstract
Abstract Background Pathogenic loss-of-function variants in the MYBPC3 gene are the leading genetic cause of hypertrophic cardiomyopathy (HCM). Biallelic loss-of-function variants are uniformly fatal in infancy, while phenotypic manifestations for individuals who are heterozygous remain less well understood. To bridge this gap, we analyzed data from MyCLIMB, a global natural history study of pediatric patients with MYBPC3+HCM, to better understand disease progression and its relationship to genotype and ultimately guide development of emerging therapies such as gene replacement therapy. Methods MyCLIMB is designed to characterize the natural history of pediatric patients (<18 years) with cardiomyopathy due to pathogenic or likely pathogenic (P/LP) MYBPC3 variants. We obtained clinical and genetic data from 27 centers across the US, Canada, Spain and UK. As of 31 January 2025, 169 retrospective and 39 prospective patients were enrolled in MyCLIMB. This study was enriched for severe MYBPC3-associated HCM pediatric patients, including biallelic. 78 asymptomatic individuals were excluded from analysis. Patients were classified by genetic inheritance (homozygous, compound heterozygous, and heterozygous). Demographics, genotype, echocardiographic measures, prevalence of and time to major cardiac-related events were compared across cohorts with standard statistical measures. Results Homozygous infants (n=30) were diagnosed at a median age of 0.3 years and 87% of them experienced death or heart transplant by a median age of 0.53 years. Compound heterozygous children (n=11) were diagnosed at a median age of 2.9 years and 27% of them experienced death or heart transplant by a median age of 6.95 years and 30.8% experienced a heart-failure related hospitalization by a median age of 3.33 years. The prevalence of Ventricular Arrhythmia composite was 29.3% in heterozygous patients vs 72.7% in compound heterozygous, while prevalence of HF composite was 14.1% vs 36.4%, respectively. Heterozygous children (n=92) were diagnosed at a median age of 5.4 years, and had a median left ventricular mass indexed to body surface area (LVMI) of 104.5 (n=40), with heart failure associated hospitalizations of 30.4% and arrythmia-related events of 6.5%. Conclusions Homozygous patients had severe disease where majority died or received a heart transplant within the first eight months of life. Compound heterozygous MYBPC3+ HCM patients experienced a significant burden of disease and high prevalence of HF-related hospitalization and death or transplant. Severely affected heterozygous children experienced significant burden of heart failure hospitalizations and arrhythmia. Our results demonstrate the presence of significant and varying disease burden of MYBPC3+ HCM in pediatric patients, confirming the importance of genetic testing, close monitoring, and suggesting that children may also benefit from targeted effective treatments, including gene therapies.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.003 | 0.003 |
| Meta-epidemiology (narrow) | 0.000 | 0.000 |
| Meta-epidemiology (broad) | 0.000 | 0.000 |
| Bibliometrics | 0.001 | 0.001 |
| Science and technology studies | 0.001 | 0.000 |
| Scholarly communication | 0.001 | 0.000 |
| Open science | 0.000 | 0.001 |
| Research integrity | 0.000 | 0.000 |
| Insufficient payload (model declined to judge) | 0.003 | 0.001 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".